CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.80 Bn | 3.50 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 3.04 Bn | 3.04 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.64 Bn | 2.64 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 1.98 Bn | 1.82 Bn | 56.40 Mn | 377.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 822,551.00 |
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | 343,924.00 |
| Jun 30, 2025 | 354,828.00 |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | -21,555.00 |
| Jun 30, 2024 | -2.91 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | 219.24 Mn |
| Jun 30, 2023 | 11.59 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | -219.12 Mn |
| Sep 30, 2022 | -17.84 Mn |
| Jun 30, 2022 | -11.61 Mn |
| Mar 31, 2022 | 253,059.00 |
| Dec 31, 2021 | 2.80 Mn |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 18.35 Mn |
| Mar 31, 2021 | 2.56 Mn |